POINT: HER2-Targeted Combinations in Advanced HER2-Positive Breast Cancer

Oncology (Williston Park). 2015 Nov;29(11):797-8, 802.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / chemistry
  • Breast Neoplasms / drug therapy*
  • Female
  • Humans
  • Lapatinib
  • Quinazolines / administration & dosage
  • Receptor, ErbB-2 / analysis
  • Receptor, ErbB-2 / antagonists & inhibitors*
  • Trastuzumab / administration & dosage

Substances

  • Antibodies, Monoclonal, Humanized
  • Quinazolines
  • Lapatinib
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • pertuzumab
  • Trastuzumab